Assembly Biosciences, Inc. (ASMB): R&D Expense
$64.81M
Year ended 2025-12-31
$63.65M
Trailing 12 months to 2026-06-30
-2.5%
3-year compound annual growth
-9.5%
5-year compound annual growth
+13.4%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $64.81M | +15.9% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $55.93M | +14.4% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $48.90M | -30.1% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $69.98M | +2.1% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $68.52M | -35.9% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | $106.82M | +24.6% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $85.76M | +17.9% | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | $72.74M | +64.5% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $44.23M | +33.6% | 2020-03-04, From 2017-01-01 |
| 2016-12-31 | $33.09M | +80.3% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $18.36M | +71.3% | 2018-03-08, From 2015-01-01 |
| 2014-12-31 | $10.72M | -28.7% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $15.03M | -23.0% | 2015-03-16, From 2013-01-01 |
| 2012-12-31 | $19.51M | -22.8% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $25.28M | n/m | 2013-03-18, From 2011-01-01 |
| 2010-12-31 | $1.85M | -37.1% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $2.94M | n/a | 2012-03-14, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $64.81M | +15.9% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $240.28M | +38.9% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $338.93M | +42.3% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $186.83M | +11.7% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $0 | -100.0% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $68.73M | -17.6% |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $251.07M | +47.7% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $38.47M | -60.2% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $7.76M | +138.6% |
Compare ASMB, BCYC, VRDN, ABCL side by side · Screen every company in Pharmaceutical Preparations ↗